No Data
No Data
Jim Cramer on Eli Lilly and Company (LLY): 'It's Valuable'
The EU may unconditionally approve novo-nordisk a/s's acquisition of catalent.
The European Commission may unconditionally approve novo-nordisk a/s's parent company, Novo Holdings, to acquire the usa contract pharmaceutical company catalent for 16.5 billion USD.
The Trader: Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop -- Barron's
Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC
Weekly Buzz: Nvidia Falls on Near Perfect Report, but Only For a Day
Sanofi Becomes Latest Drugmaker to Challenge HHS Over 340B Drug-discount Program
Demon One : I'm looking forward to it ...